Synapse - Brian Kushner

Results (55)

A curative approach to central nervous system metastases of neuroblastoma

Meeting Abstract

Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Journal Article

Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
OncoImmunology (2018)

Fulltext@MSK | Save

Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study

Meeting Abstract

Friedman, D. N.; Wolden, S. L.; Antal, Z.; Moskowitz, C. S.; Hilden, P.; Cheung, N. K. V.; Kushner, B. H.; Tonorezos, E. S.; Carlow, D.; Oeffinger, K. C.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

Journal Article

Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Modak, S.; Kramer, K.; Roberts, S. S.; Basu, E. M.; Yataghene, K.; Cheung, N. K. V.
Oncotarget (2016)

Fulltext@MSK | Save

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: A prospective phase II study

Journal Article

Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Kramer, K.; Modak, S.; Yataghene, K.; Cheung, N. K. V.
OncoImmunology (2015)

Fulltext@MSK | Save

Osteochondroma in long-term survivors of high-risk neuroblastoma

Journal Article

Kushner, B. H.; Roberts, S. S.; Friedman, D. N.; Kuk, D.; Ostrovnaya, I.; Modak, S.; Kramer, K.; Basu, E. M.; Cheung, N. K. V.
Cancer (2015)

Fulltext@MSK | Save

When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?

Journal Article

Cheung, N. K. V.; Modak, S.; Ostrovnaya, I.; Roberts, S. S.; Basu, E. M.; Kramer, K.; Kushner, B. H.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Key role for myeloid cells: Phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma

Journal Article

Cheung, N. K. V.; Cheung, I. Y.; Kramer, K.; Modak, S.; Kuk, D.; Pandit-Taskar, N.; Chamberlain, E.; Ostrovnaya, I.; Kushner, B. H.
International Journal of Cancer (2014)

Fulltext@MSK | Save

Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma

Journal Article

Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, I. Y.; Cheung, N. K. V.
OncoImmunology (2013)

Fulltext@MSK | Save

Reply to L. Moreno et al

Journal Article

Cheung, N. K. V.; Cheung, I. Y.; Ostrovnaya, I.; Kushner, B. H.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save